On 17 July 2026, the European Commission adopted 14 decisions by delegated procedure, covering merger clearances, corrigenda, financing measures, and regulatory approvals. The decisions were taken under the delegation of powers from the College of Commissioners, as recorded in document SEC(2026)195.
The Commission cleared four mergers under Article 6(1)(b) of the EU Merger Regulation and Article 57 of the EEA Agreement. These involve Volkswagen, Rheinmetall, and KS Huayu Alutech (case M.12425); EVH GE, HSBC, and EGE Döllnitz (M.12374); Al-Mukhazin, Roshn, and a joint venture (M.12463); and Munich Re, Oaktree, and Partnership (M.12469). All were found compatible with the internal market.
one to a State aid decision under Articles 107-108 TFEU, and one to Regulation (EU) 2026/78 on cosmetic substances containing carcinogenic, mutagenic, or reprotoxic substances.
Under restrictive measures, the Commission adopted an implementing regulation amending for the 358th time Council Regulation (EC) No 881/2002 concerning ISIL/Al-Qaida sanctions. This is a routine update to the EU's autonomous sanctions list.
On foreign policy, the Commission approved two financing decisions under the European Peace Facility: support for Senegal's Armed Forces within the Yaoundé Architecture, and support for establishing a Middle East zone free of weapons of mass destruction. Both are part of the EU's common foreign and security policy.
In the internal market, the Commission submitted observations on draft technical regulations notified by Romania (PT C 15-2025) and Austria (2026/224/AT) under Directive (EU) 2015/1535, which requires member states to notify technical standards to prevent barriers to trade.
For international partnerships, a financing decision for Somalia for 2026 was adopted, continuing EU development cooperation.
In the health sector, the Commission granted a marketing authorisation for "Liraglutide STADA" (liraglutide) for human use, and assessed confidentiality for the renewal of the feed additive AveMix 02 CS for weaned piglets.
Finally, the Legal Service approved powers in litigation before the Court of Justice.
These decisions, taken without a formal College meeting, reflect the routine exercise of delegated powers across multiple policy areas. The most directly affected stakeholders are the merging companies (Volkswagen, Rheinmetall, Munich Re, etc.), which gain regulatory certainty; EU taxpayers, who fund the European Peace Facility and development aid; and patients and farmers, who benefit from new medicinal products and feed additives. No major trade-offs are apparent, as the decisions are largely procedural or follow established frameworks.